We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Manifesto to Improve Lives of COPD Patients

By HospiMedica staff writers
Posted on 09 Dec 2002
In Europe, 19 patient associations have formed the European Network of Chronic Obstructive Pulmonary Disease (COPD) Patients' Association (ENCPA) to launch the first patient manifesto outlining the rights of COPD patients and challenging healthcare professionals to improve their lives. More...
The manifesto was announced on November 20, 2002, to coincide with World COPD Day.

COPD is Europe's fifth largest killer, says ENCPA, and its prevalence is projected to rise. Despite this, recognition and diagnosis of the disease are low. An estimated 75% of people in Europe with COPD are unaware they have the disease.

A key point of the manifesto is the need to improve prevention strategies that outline the key risk factors for COPD: tobacco smoke and occupational exposure to dusts and air pollution. Early diagnosis is also seen as a critical factor, to ensure that effective treatment strategies can be started at the early stages of the disease and help slow the decline in quality of life.

"Our manifesto clearly sets out our demands to European policy makers and healthcare professionals to make a change. COPD is reaching epidemic proportions, so we must work together to ensure that predicted increases in the personal and economic burden never become reality,” said Erkka Valovirta, president of the European Federation of Allergy and Airways Diseases Patients' Associations (EFA), which includes ENCPA and represents more than 100 million allergy, asthma, and COPD patients in Europe.




Related Links:
EFA

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.